Strategic Patent Solutions for Biotech Startups

Grotepatent

Grote Biotech Patent Law aims to serve biotechnology startups by offering strategic IP advice and patent services at affordable, fixed rates.

My goal is to create and execute bespoke patent strategies that will help clients attract and retain investors.

Let’s have a conversation about how I can serve your IP needs.

Eric Grote, JD, PhD

Eric founded Grote Biotech Patent Law in 2025 after spending over a decade mastering his craft at two major law firms (WSGR and Morgan Lewis) and a cancer therapeutics company. The scientific expertise he acquiredi as a cell biologist at Johns Hopkins (principal investigator), Yale (postdoc), UCSF (PhD) and MIT (undergrad) allows him to quickly and deeply understand complex inventions and build rapport with academic scientists.

As a patent attorney, Eric has advised on patents claiming diverse life science technologies including therapeutic antibodies, CAR T cells, antibody drug conjugates, T cell engagers, stem cells, cellular replacement therapies, CRISPR, molecular diagnostics, gene therapy, vaccine platforms, immune response regulators, probiotics, and more.

Eric is licensed by the USPTO and the California bar.

Services

Intellectual property will be among the most valuable assets your company creates, so it’s critical to prevent others from copying your innovations.

Strategic IP Advice

Creating an IP strategy tailored to your technology and business plans

View Now

Patent Drafting

Preparing a patent application that describes and claims the full scope of your invention

View Now

Patent Prosecution

Filing your patent application and responding to patent examiner comments

View Now

Freedom To Operate

Analyzing scope and validity of third-party patents to identify potential risks

View Now

What’s happening

Get The Latest Insights